Tat Oyi-Cys22

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTat Oyi-Cys22
Drug Alias Nameprotein subunit vaccine (Pecan Biotherapeutics/Centre National de la Recherche Scientifique/Universite de la Mediterranee)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAix-Marseille University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPecan Biotherapeutics IncCentre National De La Recherche Scientifique (Cnrs)Aix-Marseille University
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A